Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
The Left Atrium

Deathbed disputation

Peter Singer
CMAJ April 16, 2002 166 (8) 1070-1071;
Peter Singer
Ira W. DeCamp Professor of Bioethics, Princeton University Princeton, NJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Death talk: the case against euthanasia and physician-assisted suicide Margaret Somerville Montreal & Kingston: McGill-Queen's University Press; 2001 436 pp $75 (cloth) ISBN 0-773522-01-8 $24.95 (paper) ISBN 0-773522-45-X

Figure

Figure.

Honesty requires, Margaret Somerville writes in Death Talk, that those who engage in the euthanasia debate disclose their position. She is against euthanasia. When I began reading her book, I was for legalizing voluntary euthanasia. Having finished her book, I still am.

The most personal and moving passage in Death Talk helped persuade me not to change my mind. Somerville was telephoned in Canada and told that her Australian father had brain metastases and would soon die. She flew to Australia and found him incoherent and in great pain. She insisted that a pain specialist be brought in. His treatment was changed, his pain controlled, and he lived “almost pain free” for another nine months. He told his daughter that “he wanted to live as long as he could — but not if he had to endure such terrible pain” and that he wanted her to do something to help others in the same situation. Somerville adds, in parentheses, “Probably not many of them had daughters who would ‘go berserk’ as he described me as having done, in order to obtain essential pain-relief treatment.”

It isn't hard to believe that when a professor of law who is also the director of the McGill Centre for Medicine, Law and Ethics goes “berserk” in a hospital ward, her father's treatment would improve. But what about the unfortunate 99.999% of patients who do not have such well-qualified and passionate advocates? The sad reality is that many dying patients will continue to endure severe pain. Somerville's father said he would rather die than experience such pain. Yet his daughter is telling patients in his position that they must live on.

In addition to patients like Somerville's father, who can be helped by better treatment, there are others who experience terrible pain that cannot be relieved, short of being rendered unconscious. Or they may suffer other distressing symptoms such as nausea, weakness and breathlessness. These patients should not be permitted to choose death, according to Somerville.

What argument does Death Talk offer in defence of overriding a patient's considered views in this most intimate of decisions? For a thick book, astonishingly little. This can be explained in part by the fact that the book is a collection of essays. Many essays go over ground already covered by preceding essays. For example, the question of how to define euthanasia is discussed, in essentially similar terms, in chapters 3, 5 and 7; the recent upsurge of interest in euthanasia is accounted for in chapters 3 and 6; the decision in the Rodriguez case is analyzed in chapters 3, 4 and 7; and an overlapping set of issues about pain relief are presented in chapters 11, 12 and 13. That a well-known professor should be invited to so many congresses that she has to give essentially the same paper on several occasions is understandable; that she should compile them in a single volume without eliminating duplication is less excusable.

One would expect a book of more than 400 pages about voluntary euthanasia and physician-assisted suicide to include detailed examinations of the situation in Oregon, where physician-assisted suicide has been legal since 1997, and the Netherlands, where for 20 years physicians have openly carried out voluntary euthanasia, and where the practice is now legal under specified conditions. But Somerville makes only passing references to Oregon, and her knowledge of the situation in the Netherlands appears shaky. In an exchange with Torsten Nielsen, an advocate of legalized euthanasia, she takes him to task for relying on a 1990 Dutch study that was repeated in 1995 “with different results in relevant and important aspects.” Nielsen responds that the results of the 1995 study were not much different from those of the 1990 study. Somerville then claims that the 1995 study “provides evidence of serious abuses of euthanasia” but fails to specify in what way this evidence is different in the later study. (It isn't.) Nor does she tell her readers that much of what she describes here as “serious abuses” is exactly what she describes elsewhere as good medical practice: namely, withholding or withdrawing life support, or giving life-shortening doses of pain-relieving drugs. The only difference is that the more direct and honest Dutch study is prepared to describe such acts as medical decisions that shorten life, whereas Somerville focuses not on what a doctor knows the dose will do, but on what a doctor, in the privacy of his or her conscience, “intends” it to do (supposedly, to relieve pain, not shorten life).

Somerville cites no evidence to support the conclusion that, judged by the criteria used in the Dutch studies, doctors end the lives of more nonconsenting patients in the Netherlands than in any other country where euthanasia is illegal. Indeed, there is considerable evidence from several studies, including one that I carried out with colleagues in Australia, to suggest exactly the opposite: where voluntary euthanasia cannot be discussed openly, doctors end the lives of more patients without obtaining the informed and considered consent of the patient.1,2

Nor does Somerville ask why, if there is so much serious abuse of euthanasia in the Netherlands, both houses of the Dutch parliament were prepared to vote overwhelmingly, after the publication and widespread discussion of both the 1990 and 1995 studies, to legalize a practice that had, hitherto, merely enjoyed immunity from prosecution. Nor does she consider why the Netherlands' neighbour, Belgium, appears ready to follow the Dutch example and become the next country to legalize voluntary euthanasia.

Perhaps Somerville is not much interested in the facts because her opposition to euthanasia rests on something so vague that facts are scarcely relevant. She wants us to “think in terms of the secular sacred.” The “secular sacred” is apparently something that we “have allowed science to obscure,” but Somerville doesn't do much to dispel this obscurity. She wants us to develop a new sense of community and to focus on “trust and responsibility” rather than on individual rights. But trust is not an argument against voluntary euthanasia. The Dutch trust their doctors not to leave them to their suffering when they can't bear it any more and want to die. Somerville tells us that we “need to sing ‘the song of life: the lyrics of love,’” but she never tells us how these lyrics will help those who, terminally ill and in pain or distress, see no point in enduring another month, week, or day of a life that has sunk forever below the level they consider acceptable. Why should they not be allowed to choose their own song?

Peter Singer Ira W. DeCamp Professor of Bioethics Princeton University Princeton, NJ

References

  1. 1.↵
    Kuhse H, Singer P, Baume P, Clark M, Rickard M. End-of-life decisions in Australian medical practice. Med J Aust 1997;166(4):191-6.
    OpenUrlPubMed
  2. 2.↵
    Deliens L, Mortier F, Bilsen J, Cosyns M, Vander Stichele R, Vanoverloop J, et al. End-of-life decisions in medical practice in Flanders, Belgium: a nationwide survey. Lancet 2000;356 (9244): 1806-11.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

CMAJ
Vol. 166, Issue 8
16 Apr 2002
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Deathbed disputation
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Deathbed disputation
Peter Singer
CMAJ Apr 2002, 166 (8) 1070-1071;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Deathbed disputation
Peter Singer
CMAJ Apr 2002, 166 (8) 1070-1071;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • Deathbed disputation: a response to Peter Singer
  • Google Scholar

More in this TOC Section

  • Chronicles of a cardiologist in Canada's North
  • Rethinking randomized controlled trials
  • The impetus to cure
Show more The Left Atrium

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire